Becton, Dickinson and Company — Company profile
Healthcare · Medical Instruments & Supplies · United States
Last price 197.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 53.90B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Details
| Name | Becton, Dickinson and Company |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 72000 |
| Founded | 1897 |
| Ipo Date | 1962-04-23 |
| Ceo | Thomas Polen |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| Isin | US0758871091 |
| Cusip | 075887109 |
| Cik | 0000010795 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Thomas E. Polen Jr. | President, Chief Executive Officer and Chairman |
| Michael C. Feld | Executive Vice President and Chief Revenue Officer |
| Vitor Roque | Executive Vice President and Chief Financial Officer |
| Elizabeth McCombs | Executive Vice President and Chief Technology Officer |
| Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. | Senior Vice President and Chief Scientific Officer |
| Arthur Hu | Executive Vice President and Chief Information and Digital Officer |
| Shawn C. Bevec | Senior Vice President of Investor Relations |
| Lanesha T. Minnix J.D. | Executive Vice President and General Counsel |
| Carla Burigatto | Senior Vice President and Chief Communications Officer |
| Meera Gopalakrishnan | Senior Vice President and Global Chief Marketing Officer |
Contact
| Address | 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, United States |
| Phone | 201 847 6800 |
| Website | https://www.bd.com |